A Novel Monoclonal Antibody for detection of a new patented synthetic “NE” fusion protein tag

A novel fusion protein tag, named “NE” - was designed as a tool for detection and purification of recombinant protein. This sequence is composed of 18 hydrophilic amino acids which does not share significant homology to any existing native protein. This synthetic peptide has least ordered secondary structure with strong immunogenicity. These properties offer stringent specificity to NE-tagged proteins, which are readily to be detected, quantitated, and purified.

Monoclonal anti-NE detection antibody is an affinity purified mouse immunoglobulin, IgG1, which binds to NE fusion proteins. This antibody is useful in a wide spectrum of applications including Western blotting, immunocytochemistry, immunoprecipitation, and affinity purification of NE fusion proteins when bound to solid support.

Applications: Protein detection, tracing, purification and quantification

Read Specification and Buy

NE Peptide Tag Sequence "TKENPRSNQEESYDDNES"

Not Found in Nature
Stringent antibody specificity
Hydrophilic Amino Acids
Good water solubility
Strong Immunogenicity
Minimal denaturation or inactivation of tagged proteins
Minimal secondary structure
100% Random Coil
Good antibody accessibility
Patented in US, Europe and China
US8927225, EP2328909, CN102203119


Computational simulation of NE peptide tag showing linear conformation for maximal solvent accessibility


C84H128 N26 O40

Chemical Formula

2142.07 g/mol

Molecular Weight

pH 3.84

Isoelectric Point
(Net charge at pH 7: -4)

1280 cm-1M-1

Extinction coefficient

Good Surface Accessibility of “NE” peptide tag

Prediction method: Bent Petersen, Thomas Nordahl Petersen, Pernille Andersen, Morten Nielsen and Claus Lundegaard. A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Structural Biology (2009) 9:51.

A B C D E F G H I
1TE0.856118.755-0.4070.0030.0030.994
2KE0.63129.612-0.7160.1130.0430.844
3EE0.655114.516-1.30.1130.0430.844
4NE0.5174.664-1.050.1150.0160.868
5PE0.33447.395-1.9090.1810.0160.803
6RE0.497113.699-0.6840.2570.0160.727
7SE0.49357.768-1.2480.3390.0160.645
8NE0.48570.975-1.3340.3390.0160.645
9QE0.42275.298-0.6150.430.0160.555
10EE0.55296.452-0.640.4550.0460.498
11EE0.55496.714-0.3780.4550.0460.498
12SE0.45653.42-1.2650.3540.0480.598
13YB0.23951.053-0.2470.2570.0160.727
14DE0.5376.301-0.7230.2570.0160.727
15DE0.52976.272-1.5580.2570.0160.727
16NE0.58886.112-2.7110.1810.0160.803
17EE0.642112.14-1.4310.1150.0160.868
18SE0.902105.714-0.270.0030.0030.994

Column A: Amino acid number
Column B: Amino acid
Column C: Class assignment – B for buried or E for Exposed – Threshold: 25% exposure, but not based on RSA
Column D: Relative Surface Accessibility – RSA
Column E: Absolute Surface Accessibility
Column F: Z-fit score for RSA prediction
Column G: Probability for Alpha-Helix
Column H: Probability for Beta-Strand
Column I: Probability for Coil


Mouse monoclonal NE© antibody, clone 5F6
For detection of a novel fusion protein tag

Production of mouse monoclonal anti-NE antibody


Read Specification and Buy

Validated Applications


Western blotting

(protein detection & quantification)

Western blotting

Immunocytochemistry

(Intracellular localization)

Immunocytochemistry

Immunoprecipitation

(protein-protein interaction)

Immunoprecipitation

Publications

  1. Ho PWL, Tse ZHM, Liu HF, Lu S, Ho JWM, Kung MHW, Ramsden DB and Ho SL. Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based system. PLoS ONE. 2013; 8(9):e74065.
  2. Tse HF, Ho JC, Choi SW, Lee YK, Butler AW, Ng KM, Siu CW, Simpson MA, Lai WH, Chan YC, Au KW, Zhang J, Lay KW, Esteban MA, Nicholls JM, Colman A, Sham PC. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum Mol Genet. 2013; 22(7):1395-403.
  3. Xu EG, Ho PWL, Tser Z, Ho SL, Leung KM. Revealing ecological risks of priority endocrine disrupting chemicals in four marine protected areas in Hong Kong through an integrative approach. Environ Pollut.2016; 215:103-112.

Read Specification and Buy

How to incorporate NE fusion protein tag into your target protein

Simply substitute your desired restriction site (R/S) and cDNA sequence of your gene-of-interest (G.O.I.)

… Your primers are ready to order and proceed.

Instruction: Please click on the R/S and XXXXXXXXXX below to edit your target primer sequence.

N-terminal tag

N-terminal tag

Forward Primer Builder

5’-R/S —gCCACC—ATG—ACCAAAgAAAACCCgCgTAgCAACCAggAAgAAAgCTATgATgATAACgAAAgC—XXXXXXXXXX (G.O.I.)-3’

NE sequence

Approximate Melting point: 68.4℃ ; G.C control: 48%

C-terminal tag

N-terminal tag

Reverse Primer Builder (reverse complement)

5’-R/S —TTA—gCTTTCgTTATCATCATAgCTTTCTTCCTggTTgCTACgCgggTTTTCTTTggT—LinkerXXXXXXXXXX (G.O.I.)-3’

NE sequence

 

Remember to reverse complement your cDNA sequence for a reverse primer

Approximate Melting point: 68.4℃ ; G.C control: 48%

Read Specification and Buy

"We invite you to bring this new protein tag and antibody into your research!"

Research Team

Dr. David B. RAMSDEN, PhD

Dr. Matthew Chi-Ting LEUNG, PhD

Dr. Colin Siu-chi LAM, PhD

Dr. Hui-Fang LIU, PhD

AddressDivision of Neurology,
Department of Medicine,
The University of Hong Kong,
Li Ka Shing Faculty of Medicine Building,
21, Sassoon Road, Hong Kong.
Telephone852-2255 3315

Contact Person

Dr Philip Wing-Lok Ho (何永樂), PhD

Emailhwl2002@hku.hk
HKU Scholar Hubhttp://hub.hku.hk/rp/rp00259

get free trial image get free trial image


All Rights Reserved. | Legal Terms | Privacy